The present study sought to determine the role of vitamin D and zinc in protecting against nicotine stress by altering the alveolar response and modulating antioxidant mechanisms. Thirty mature adults Wistar rats, used as a model for mammals, were maintained at 23 ± 2 C°, randomly divided into five equal groups, and then given therapy for 14 days. G1: Nicotine was administered at a dose of 0.0015g/kg b.w. I.P., G2: zinc was administered orally at 0.06 g/kg b.w., G3: Orally administration vitamin D at 250 µg/kg b.w., and G4: both zinc and vitamin D were administered orally at the same dose as nicotine, 0.0015g/kg b.w. I.P. Rats were anesthetized with ketamine at the end of the treatment period. All groups of rats had lung samples extracted rapidly; alveolar groups of samples were cleaned and placed in physiological used 10% of neutral buffered formalin for tissue fixation. Then lung suction were repaired for histopathological study. The results showed highly significant protective effects of zinc and vitamin D in the tissues of the lung in G4. Zinc and vitamin D group G4 decreased the effectiveness of nicotine when compared with the G1 nicotine group. Protective effect of zinc and vitamin D by decreased MNCS infiltration with thickening and slightly congested pulmonary blood vessels without emphysema and pulmonary edema
No takes yet. Share an insight, caveat, or question.
Hamady et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: